AAAAI logo

Home

Allergy & Asthma Disease Management Center
Funded by an educational grant from sanofi-aventis US


Ask the Expert Current Literature Quiz of the Month Allergy/Respiratory Digest CME Article Meetings/Calendars AAAAI Educational Resources Other Links Comments/Suggestions



AND THE ANSWER IS . . .

2

Discussion
Allergy to NRL is a significant problem in healthcare personnel with evidence of sensitivity in up to 15% of hospital-based nurses. The major sources of airborne NRL allergens are powdered rubber gloves. Therefore, most of the hospital personnel who become sensitized in environments where sterile powdered NRL gloves are donned and removed (operating and post-op suites, rooms for sterile procedures). A careful study of airborne NRL allergen levels has shown the highest levels in such environments with much lower (frequently undetectable) levels in other hospital sections, particularly administrative areas. Thus many individuals allergic to NRL can be switched to jobs in these 'low NRL allergen' areas of the hospital. It should be noted that NRL allergen is exposed in 'dipped' products such as gloves but not in 'hard rubber' products such as stoppers.

The diagnosis of allergy to NRL can be made by one of the FDA-approved in vitro anti-NRL IgE antibody tests in about 80-90% of cases. A prick skin test using an ammoniated latex extract, while not yet FDA approved, can detect NRL allergy in some individuals with negative anti-NRL IgE antibody tests. Occasionally this type of allergy can be detected in individuals with negative in vitro/skin tests by a provocative challenge testing.

Allergies to certain foods such as bananas, kiwis, chestnuts, avocados are clinically manifest in about 25-50% but not all of those allergic to NRL. Cross-sensitivity tips between these foods and NRL allergens may be found in a higher percentage of cases, some of whom tolerate ingestion of these foods.

Attempts to develop a safe immunotherapy program for NRL program have been made for some time with variable results. However, at present, there is not yet an approved NRL immunotherapy protocol.

References
1. Clin Infect Dis 2004;38:252-6
2. Immunol Allergy Clin North Am 2003;23:205-19



Please tell us what you think of this site.